Antiretroviral Therapy Dynamics in HIV Treatment

Antiretroviral therapy dynamics encompass the complex interplay between drug regimens, viral kinetics and host immune responses in the management of HIV infection. Since the introduction of combination therapy in the mid-1990s, treatment strategies have evolved from multi-pill schedules to once-daily fixed-dose combinations and long-acting injectable formulations, improving adherence and antiviral potency. Achieving and sustaining virological suppression relies on optimised pharmacodynamics, timely detection of resistance through viral load monitoring and strategic regimen changes upon failure. Routine measurement of CD4+ T cell counts guides risk assessment for opportunistic infections and informs decisions on prophylaxis and treatment intensification. At the population level, widespread antiretroviral coverage has transformed HIV from a fatal disease into a manageable chronic condition with near-normal life expectancy, while reducing transmission via treatment as prevention. Global scale-up has highlighted challenges in adherence, equity of access and retention in care, spurring innovations in digital health interventions and differentiated service delivery. Current research spans molecular analyses of viral reservoirs to large-scale cohort evaluations of real-world regimen effectiveness, underlining efforts to refine therapeutic approaches, close gaps in the care continuum and progress towards functional cure strategies.

Research from Nature Portfolio

Recent studies have compared modern initial antiretroviral regimens in large resource-limited cohorts in China, revealing differential impacts on all-cause and AIDS-related mortality across first-line therapies. In a retrospective multicentre analysis of over 40 000 individuals starting treatment between 2017 and 2019, regimens incorporating integrase strand transfer inhibitors such as dolutegravir demonstrated superior survival outcomes compared with older non-nucleoside inhibitor-based therapies, primarily through reductions in AIDS-related deaths. These findings have guided updates to national protocols, emphasising the selection of potent, well-tolerated regimens to optimise long-term outcomes in diverse patient populations.

Antiretroviral Therapy Dynamics in HIV Treatment publication trend

The graph below shows the total number of articles in antiretroviral therapy dynamics in hiv treatment across all publications each year (not limited to Nature Index journals).

Technical terms

Antiretroviral therapy (ART): The use of a combination of drugs to suppress HIV replication, prevent disease progression and reduce transmission.

Viral load: The quantity of HIV RNA in the bloodstream, measured to assess treatment efficacy and detect failure.

CD4+ T cell count: The concentration of CD4-positive lymphocytes per microlitre of blood, reflecting immune system health and guiding prophylaxis decisions.

Integrase strand transfer inhibitor (INSTI): A class of antiretroviral drugs that block the HIV integrase enzyme, preventing viral DNA integration into host genomes.

Virological suppression: Reduction of plasma HIV RNA to undetectable levels, typically below 50–200 copies per millilitre, indicating effective viral control.

References

1. Associations of modern initial antiretroviral therapy regimens with all-cause mortality in people living with HIV in resource-limited settings: a retrospective multicenter cohort study in China. Nature Communications (2023).
2. Vital Signs: HIV Transmission Along the Continuum of Care — United States, 2016. MMWR Morbidity and Mortality Weekly Report (2019).
3. Life Expectancies of South African Adults Starting Antiretroviral Treatment: Collaborative Analysis of Cohort Studies. PLOS Medicine (2013).
4. Expansion of HAART Coverage Is Associated with Sustained Decreases in HIV/AIDS Morbidity, Mortality and HIV Transmission: The “HIV Treatment as Prevention” Experience in a Canadian Setting. PLOS ONE (2014).
5. Factors Associated with Virological Failure and Suppression after Enhanced Adherence Counselling, in Children, Adolescents and Adults on Antiretroviral Therapy for HIV in Swaziland. PLOS ONE (2015).